Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Paraganglioma × CNS × Clear all

Status

Recruiting 23 Completed 17 Unknown 13 Terminated 8 Active not recruiting 7 Withdrawn 4 Enrolling by invitation 3 Approved for marketing 2 Not yet recruiting 1 No longer available 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Neuroblastoma 5 Glioblastoma 3 Stomach Neoplasms 2 Recurrence 2 Pheochromocytoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Urinary Bladder Neoplasms 1 Typical Teratoid Rhabdoid Tumor 1 Thyroid Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Paraganglioma 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neuroectodermal Tumors, Primitive 1 Melanoma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01590680 2023-02-28

Expanded Access Protocol Using 131I-MIBG

Jubilant DraxImage Inc.

Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡